Search results
James Patrick Allison (born August 7, 1948) is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas.
About Dr. Allison. Dr. James Allison is Regental Professor and Chair of the Department of Immunology, the Olga Keith Wiess Distinguished University Chair for Cancer Research, Director of the Parker Institute for Cancer Research, Executive Director of the... Read More.
James P. Allison. The Nobel Prize in Physiology or Medicine 2018. Born: 7 August 1948, Alice, TX, USA. Affiliation at the time of the award: Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The Nobel Prize in Physiology or Medicine 2018 was awarded jointly to James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation"
Oct 1, 2018 · James P. Allison studied a known protein that functions as a brake on the immune system. He realized the potential of releasing the brake and thereby unleashing our immune cells to attack tumors. He then developed this concept into a brand new approach for treating patients.
Apr 18, 2014 · James Allison is currently chairman of immunology at The University of Texas MD Anderson Cancer Center in Houston, Texas. He serves as director of CRI’s Scientific Advisory Council, a position he assumed in 2011, when Lloyd J. Old, MD, retired (pictured together on right).
May 9, 2024 · James P. Allison, American immunologist who contributed to the discovery of mechanisms underlying T-cell activation and who was a pioneer in the development of immune checkpoint therapy for cancer. Allison was a corecipient of the 2018 Nobel Prize for Physiology or Medicine.
Oct 1, 2018 · James Allison and Tasuku Honjo pioneered treatments that unleash the body’s own immune system to attack cancer cells.
Jim Allison is professor and chair of the department of Immunology and the executive director of the Immunotherapy Platform at The University of Texas MD Anderson Cancer Center. He holds the Vivian Smith Distinguished Chair in Immunology and is deputy director of the David H. Koch Center for Applied Research in Genitourinary Cancers, Department ...
The James P. Allison Institute at MD Anderson Cancer Center advances exceptional discovery, translational and clinical research to integrate immunobiology across disciplines and unlock the full potential of science and medicine for human health.
